Key result
Metabolic syndrome was significantly associated with increased subclinical atherosclerosis markers, including higher brachial-ankle pulse wave velocity and carotid intima-media thickness, only in individuals without diabetes.
Why the study?
Does the presence of metabolic syndrome exacerbate subclinical atherosclerosis differently in patients with versus without diabetes?
Cross-Sectional (n=2,560)
Does the presence of metabolic syndrome exacerbate subclinical atherosclerosis differently in patients with versus without diabetes?
Metabolic syndrome significantly exacerbates subclinical atherosclerosis in non-diabetic individuals, whereas in established diabetes, the presence of metabolic syndrome does not confer additional atherosclerotic burden.
Answers are grounded in this paper and cite their sources.
May support atherosclerosis monitoring for metabolic syndrome in non-diabetics but not diabetes; hypothesis-generating.
BACKGROUND: Metabolic syndrome (MS) is associated with increased risks of diabetes and atherosclerotic cardiovascular disease. However, data on the impact of MS and its individual components on subclinical atherosclerosis (SCA) according to diabetes status are scarce. METHODS: Surrogate markers of SCA, brachial-ankle pulse wave velocity (baPWV), and carotid intima-medial thickness (IMT) and plaque were assessed in 2,560 subjects (60 ± 8 years, 33% men) who participated in baseline health examinations for a community-based cohort study. RESULTS: The participants included 2,149 non-diabetics (84%) and 411 diabetics (16%); 667 non-diabetics (31%) and 285 diabetics (69%) had MS, respectively. Diabetics had significantly higher baPWV and carotid IMT, and more plaques than non-diabetics (p < 0.001, respectively). Individuals with MS had significantly higher baPWV and carotid IMT than those without MS only among non-diabetics (p < 0.001, respectively). Among MS components, increased blood pressure was significantly associated with the exacerbation of all SCA markers in non-diabetics. The number of MS components was significantly correlated with both baPWV and carotid IMT in non-diabetics (baPWV: r = 0.302, p < 0.001; carotid IMT: r = 0.217, p < 0.001). Multiple regression showed both MS and diabetes were significantly associated with baPWV (p < 0.001, respectively), carotid IMT (MS: p < 0.001; diabetes: p = 0.005), and the presence of plaque (MS: p = 0.041; diabetes: p = 0.002). CONCLUSIONS: MS has an incremental impact on SCA in conditions without diabetes. The identification of MS and its individual components is more important for the risk stratification of CVD in non-diabetic individuals.
No takes yet. Share an insight, caveat, or question.
Won et al. (2013) conducted a cross-sectional in Metabolic Syndrome and Subclinical Atherosclerosis (n=2,560). Metabolic syndrome vs. No metabolic syndrome was evaluated on Brachial-ankle pulse wave velocity (baPWV) in non-diabetic subjects (p=<0.001). Metabolic syndrome was significantly associated with increased subclinical atherosclerosis markers, including higher brachial-ankle pulse wave velocity and carotid intima-media thickness, only in individuals without diabetes.
Synapse has enriched 10 related papers. Consider them for comparative context: